Skip to main content
SpringerLink
Log in
Book cover

Praxisbuch Gynäkologische Onkologie pp 101–129Cite as

Maligne epitheliale Tumoren des Ovars

  • Chapter
  • First Online:

  • 2757 Accesses

Zusammenfassung

Ein effektives Screening existiert beim Ovarialkarzinom nicht. Die Verdachtsdiagnose eines Ovarialkarzinoms macht eine operative Abklärung mit histologischer Diagnosesicherung durch Laparotomie oder Laparoskopie notwendig. Es existiert keine präoperative Untersuchungsmethode, die eine Operation ersetzen könnte. Die Operation des Ovarialkarzinoms beginnt mit einer genauen und systematischen Exploration des gesamten Abdomens, mit dem Ziel, die Tumorausbreitung zu erfassen und die Operabilität zu beurteilen (operatives Staging). Bei fortgeschrittenem Karzinom erfolgt eine maximale Tumorreduktion im Becken und Abdomen mit dem Ziel, keinen Resttumor zurückzulassen (= optimales „Debulking“, R0-Resektion). Patientinnen mit einem Ovarialkarzinom im Stadium FIGO Ic oder Ia/Ib und Grad 3 sollen eine platinhaltige Chemotherapie über 6 Zyklen erhalten. Ab dem Stadium II ist eine Chemotherapie mit Carboplatin und Paclitaxel Standard. Bevacizumab kann zusätzlich verabreicht werden.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  • Aghajanian C, Blank S, Goff B, Judson P, Teneriello M, Husain A, Sovak M et al (2012) Oceans: A randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol 30:2039–2045

    Article  CAS  Google Scholar 

  • Benedetti-Panici P, Maggioni A, Hacker N et al (2005) Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97:560–566

    Article  Google Scholar 

  • Burger R, Brady M, Bookman M, Fleming G, Monk B, Huang H et al (2011) Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med 365:2473–2483

    Article  CAS  Google Scholar 

  • Collaborative Group on Epidemiological studies of ovarian cancer (2015) Monopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet 385:1835–1842

    Article  Google Scholar 

  • DuBois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase III multicenter trials: by the Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe Ovar (AGO-Ovar) and the Groupe d´Investigateurs Nationaux pour les etudes des cancers de l’ovarie (GINECO). Cancer 115:1234–1244

    Article  CAS  Google Scholar 

  • DuBois A, Riegler E, De Gregorio N, Reuss A, Mahner S, Fotopoulou C et al (2013) Borderline tumors of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie. Eur J Cancer 49:1905–1914

    Article  Google Scholar 

  • DuBois A, Vergote I, Ferron GH, Reuss A, Meier W, Greggi S et al (2017) Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: The interim analysis of AGO DESKTOP III/ENGOT ov20. J Clin Oncol 35, 15 Suppl, Abstr 5501

    Google Scholar 

  • Eeles R, Morden J, Gore M, Mansi J, Glees J, Wenczl M et al (2015) Adjuvant hormone therapy may improve survival in epithelial ovarian cancer: Results of the AHT randomized trial. J Clin Oncol 33:4138–4144

    Article  CAS  Google Scholar 

  • Gershenson D, Bodurka D, Coleman R, Lu K, Malpica A, Sun C (2017) Hormonal maintenance therapy for women with low-grade serous cancer of the ovary or peritoneum. J Clin Oncol 35:1103–1111

    Article  Google Scholar 

  • Harter P, Sehouli J, Lorusso D, Reuss A, Vergote I, Marth C et al (2017) LION – Lymphadenectomy in ovarian neoplasms: A prospective randomized AGO study group led Gynecologic Cancer Intergroup trial. J Clin Oncol, 35, 15 Suppl, Abstr 5500

    Article  Google Scholar 

  • Hogdall E, Karlesn M, Christensen I, Lundvall L, Engelholm S, Nedergaard L et al (2012) Diagnostic value of HE4, CA 125, and the ROMA index in ovarian cancer patients from a tertiary center. Int J Gynecol Cancer 22(S1):S42

    Google Scholar 

  • Kaufmann M, Costa SD, Scharl A (Hrsg) (2003) Die Gynäkologie. Springer, Berlin

    Google Scholar 

  • Katsumata N, Yasuda M, Takahashi F, Isonishi S, Jobo T, Aoki D et al (2009) Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: A phase 3, open-label, randomised controlled trial. Lancet 374:1331–1338

    Article  CAS  Google Scholar 

  • Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF). S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren, Kurzversion 2.0, AWMF Registrierungsnummer 032/035OL, http://leitlinienprogramm-onkologie.de/Ovarialkarzinom.61.0html (Stand 2017)

  • Ledermann J, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G et al (2012) Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. N Engl J Med 366:1382–1392

    Article  CAS  Google Scholar 

  • Maggioni A, Benedetti-Panici P, Dell’Anna T et al (2006) Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer 95:699–704

    Article  CAS  Google Scholar 

  • Markman M, Rothman R, Hakes T et al (1991) Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. J Clin Oncol 9:389–393

    Article  CAS  Google Scholar 

  • Mirza MR, Monk B, Herrstedt J, Oza A, Mahner S, Redondo A et al (2016) Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer. New Engl J Med 375:2154–2164

    Article  CAS  Google Scholar 

  • Morice P, Wicart-Poque F, Rey et al (2001) Results of conservative treatment in epithelial ovarian carcinoma. Cancer 92: 1412–2418

    Google Scholar 

  • Pearce C, Templeman C, Rossing M, Lee A, Near A, Webb P et al (2012) Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 13:385–394

    Article  Google Scholar 

  • Perren T, Swart AM, Pfisterer J, Ledermann J, Pujade-Lauraine E, Kristensen G et al (2011) A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med 365:2484–2496

    Article  CAS  Google Scholar 

  • Petru E, Lahousen M, Tamussino K et al (1994) Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 170:656–662

    Article  CAS  Google Scholar 

  • Petru E, Kurschel S, Walsberger K et al (2003) Can bowel endoscopy predict colorectal surgery in patients with an adnexal mass? Int J Gynecol Cancer 13:292–296

    Article  CAS  Google Scholar 

  • Pignata S, Scambia G, Savarese A et al (2010) Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin in patients with advanced ovarian cancer: Final analysis of the MITO-2 randomized multicenter trial. J Clin Oncol 28 (Suppl) 952s (Abstract No. LBA5033)

    Google Scholar 

  • Pujade-Lauraine E, Wagner U, Aavall-Lundqvist E et al (2010) Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse. J Clin Oncol 28:3323–3329

    Article  CAS  Google Scholar 

  • Rosenthal A, Fraser L, Philpot S, Manchanda R, Burnell M, Badman P et al (2017) Evidence of tstage shift in women diagnosed with ovarian cancer during phase II of the United Kingdom familial ovarian cancer screening study. J Clin Oncol 35:1411–1420

    Article  Google Scholar 

  • Rustin G, Van der Burg M, Griffin C et al (2010) Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): A randomised trial. Lancet 376:1155–1163

    Article  Google Scholar 

  • Sassone M, Timor-Tritsch I, Artner A et al (1991) Transvaginal sonographic characterization of ovarian disease: Evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol 78:70–76

    CAS  PubMed  Google Scholar 

  • Schelling M, Braun M, Kuhn W et al (2000) Combined transvaginal B-mode and color Doppler sonography for differential diagnosis of ovarian tumors: results of a multivariate logistic regression analysis. Gynecol Oncol 77:78–86

    Article  CAS  Google Scholar 

  • Trimbos B, Timmers P, Pecorelli S et al (2010) Surgical staging and treatment of early ovarian cancer: Long-term analysis of a randomized trial. J Natl Cancer Inst 102:982–987

    Article  Google Scholar 

  • Vang R, Shih lM, Kurman J (2009) Ovarian low-grade and high-grade serous carcinoma: Pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol 16: 267–282

    Article  Google Scholar 

  • Vergote I, Brabanter J, Fyles A et al (2001) Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 357:176–182

    Article  CAS  Google Scholar 

  • Vergote I, Trope C, Amant F et al (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIc or IV ovarian cancer. New Engl J Med 363:943–953

    Article  CAS  Google Scholar 

  • Wagner U, Harter P, Hilpert F, Mahner S, Reuß A, DuBois A, Petru E et al (2013) S3-guideline on diagnostics, therapy and follow-up of malignant ovarian tumours. Geburtsh Frauenheilk 73:874–889

    Article  CAS  Google Scholar 

  • Winter W, Maxwell L, Tian C et al (2008) Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: A Gynecologic Oncology Group study. J Clin Oncol 26:83–89

    Article  Google Scholar 

  • Young R, Decker D, Wharton et al (1983) Staging laparotomy in early ovarian cancer. JAMA 250: 3072–3076

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Frauenheilkunde und Geburtshilfe, Medizinische Universität Graz, Graz, Österreich

    Edgar Petru, Raimund Winter & Karl Tamussino

  2. Institut für Klinische Pathologie, Vinzenz Pathologieverbund, Ordensklinikum/Krankenhaus der Barmherzigen Schwestern, Linz, Österreich

    Farid Moinfar

  3. Klinik für Gynäkologie mit Zentrum für onkologische Chirurgie und Klinik für Gynäkologie, Charité-Universitätsmedizin Berlin, Berlin, Deutschland

    Jalid Sehouli

Authors
  1. Edgar Petru
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Farid Moinfar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raimund Winter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Karl Tamussino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jalid Sehouli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Edgar Petru .

Editor information

Editors and Affiliations

  1. Universitätsklinik für Frauenheilkunde und Geburtshilfe, Medizinische Universität Graz, Graz, Austria

    Edgar Petru

  2. Klinik für Gynäkologie, UniversitätsSpital Zürich, Zürich, Switzerland

    Daniel Fink

  3. Gynäkologisch-onkologische Praxis, BrustCentrum, Privatklinik Zürich-Bethanien, Zürich, Switzerland

    Ossi R. Köchli

  4. German Breast Group Forschungs GmbH, Neu-Isenburg, Germany

    Sibylle Loibl

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Petru, E., Moinfar, F., Winter, R., Tamussino, K., Sehouli, J. (2019). Maligne epitheliale Tumoren des Ovars. In: Petru, E., Fink, D., Köchli, O., Loibl, S. (eds) Praxisbuch Gynäkologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57430-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-57430-0_6

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-57429-4

  • Online ISBN: 978-3-662-57430-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation